Evidence map›Paper›PMID 37109318›Full record

ArticleJournal of clinical medicine2023

Efficacy and Safety of Intra-Articular Cross-Linked Sodium Hyaluronate for the Treatment of Knee Osteoarthritis: A Prospective, Active-Controlled, Randomized, Parallel-Group, Double-Blind, Multicenter Study.

Tomasz Blicharski, Piotr Łukasik, Rafal Plebanski, Zbigniew Żęgota, Marek Szuścik, Erik Moster, Karel Pavelka, Seonhui Jeon, So La Park

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Tomasz BlicharskiClinic of Rehabilitation and Orthopedics, Medical University of Lublin, 20-090 Lublin, Poland.ORCID 0000-0001-9747-8817
Piotr ŁukasikTrauma and Orthopedic Ward, NZOZ Medi-Spatz, 44-100 Gliwice, Poland.
Rafal PlebanskiClinic of Healthy Bone, 90-552 Lodz, Poland.
Zbigniew ŻęgotaSpecjalistyczny Osrodek Leczniczo Badawczy (Specialist Treatment and Research Center), 14-100 Ostroda, Poland.
Marek SzuścikOrthopedic Department, Rydygier's Hospital, 31-826 Krakow, Poland.
Erik MosterRheumatic Center of Dr. Mostera, 61500 Brno, Czech Republic.
Karel PavelkaInstitute of Rheumatology, 12850 Prague, Czech Republic.
Seonhui JeonLife Sciences, LG Chem, Ltd., Seoul 07336, Republic of Korea.
So La ParkLife Sciences, LG Chem, Ltd., Seoul 07336, Republic of Korea.
LG (South Korea) · KRCentralny Ośrodek Badawczo Rozwojowy Aparatury Badawczej i Dydaktycznej (Poland) · PLInstitute of Rheumatology · CZMedical University of Lublin · PLNZOZ Medi-Spatz · PL

Funding

LG Chem T.B., T.H., A.G., J.B., P.Ł., R.P., Z.Ż., M.S., E.M., K.P., and T.T. received a study grant from LG Chem, Ltd. S.J. and S.L.P. are full-time employees of LG Chem, Ltd
6 · The paper itself

Abstract

The safety and efficacy of Hyruan ONE (test product), an intra-articular cross-linked sodium hyaluronate injection, to treat mild-to-moderate knee osteoarthritis was compared with that of Durolane (comparator) in a prospective, active-controlled, parallel-group, double-blind (masked-observed), multicenter non-inferiority study. European patients (

Indexed as

intra-articular hyaluronic acidkneetherapeuticsviscosupplementation

Identifiers

PMID37109318
PMCPMC10145240
OpenAlexW4366598258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.